ASSET PURCHASE AGREEMENT (“Agreement”) by and between Broaden Bioscience and Technology Corp and Orgenesis, Inc. effective as of July 10, 2024 (“Effective Date”)Asset Purchase Agreement • July 12th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
Asset being sold or transferred Broaden hereby sells and assigns to Orgenesis and Orgenesis hereby purchases from Broaden the Product referred to in Exhibit “A” of this agreement (“Product” or “Assets”):
